WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Mohit Kumar*

ABSTRACT

While a disease-free world may be unattainable, we can strive to alleviate suffering and improve patients’ lives. The primary goal is to ensure a high quality of life for individuals. This can only be accomplished with high-quality medications that offer maximum therapeutic benefits and minimal side effects, accessible to everyone at an affordable cost. Patients depend on their physicians and prescribers for proper treatment, making it the responsibility of the physician to meet the patient’s needs satisfactorily. Drugs are typically prescribed for their beneficial effects but may cause various adverse effects. Common medications like phenylpropanolamine, analgen, cisapride, and nimesulide are frequently used without a doctor’s prescription, sold as over-the-counter (OTC) products in India, where regulatory guidelines for OTC products are still lacking. Coxibs were widely prescribed until the recent issues with rofecoxib and valdecoxib, which were withdrawn from the market by the manufacturer due to an increased risk of heart attacks and strokes with long-term use. It is essential to understand the circumstances under which these medicines were banned over time.